The lidERA trial results, presented Wednesday at the San Antonio Breast ... As the pharma and biotech editor at WTWH Media, Brian has almost ...
News
- Oral SERD giredestrant cuts recurrence risk 30% in early HR positive breast cancer
- AZ-, Gilead-backed program reduced side effects, distress in Black breast cancer patients: study
... San Antonio Breast Cancer Symposium on Wednesday. The research centers ... Fierce Biotech · Fierce Healthcare · Fierce Pharma. Our Events. Life ...
- Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday ...
... San Antonio Breast Cancer Symposium; Implications for the application of ... Explore. Health Care & Hospitals · Medical Pharmaceuticals · Biotechnology.
- Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday ...
("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology ... San Antonio Breast Cancer Symposium; Implications for the application of ...
- 1 in 4 ABC patients treated with Novartis Kisqali remain progression-free beyond 4 years
A fully integrated, R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.HK). ... biotech entity) and Shaoxing ...